Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Shares Outstanding (Weighted Average): 2021

Historic Shares Outstanding (Weighted Average) for Cardiol Therapeutics (CRDL) over the last 1 years, with Dec 2021 value amounting to $44.0 million.

  • Cardiol Therapeutics' Shares Outstanding (Weighted Average) rose 44.23% to $61.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $61.9 million, marking a year-over-year increase of 44.23%. This contributed to the annual value of $44.0 million for FY2021, which is N/A change from last year.
  • As of FY2021, Cardiol Therapeutics' Shares Outstanding (Weighted Average) stood at $44.0 million.
  • In the past 5 years, Cardiol Therapeutics' Shares Outstanding (Weighted Average) ranged from a high of $44.0 million in FY2021 and a low of $44.0 million during FY2021.
  • For the 1-year period, Cardiol Therapeutics' Shares Outstanding (Weighted Average) averaged around $44.0 million, with its median value being $44.0 million (2021).